在牛皮的secukinumab度,疾病活动和IL-17A水平之间的关系:一个横截面的观察性研究
Kouzhu Zhu1, Zhou Lu2, Lei Cao3
1Department of Pharmacy, Affiliated Children's Hospital to Jiangnan University (Wuxi Children's Hospital), Jiangsu Wuxi, China.
The Journal of dermatology
|August 5, 2025
概括
高于35.43微克/毫升的secukinumab水平与牛皮患者的最佳反应有关. 较高的体重和较低的白蛋白可能会降低药物水平,需要调整剂量以有效治疗牛皮.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 塞库金努马布已获批准用于治疗牛皮.
- 非标签的高剂量疗法用于特定的患者.
- 治疗药物监测有助于调整治疗计划.
研究的目的:
- 确定secukinumab用于牛皮的治疗值.
- 评估影响secukinumab度的患者特征.
主要方法:
- 对36名接受secukinumab维持治疗的牛皮病患者进行横截面研究.
- 牛皮病区域和严重性指数 (PASI) 用于疾病活动评估 (最佳反应≤2).
- 通过ELISA测量secukinumab的最低度.
主要成果:
- 在最佳反应的患者中,secukinumab 度的中位数较高 (35.08 与 25.94 μg/mL 相比).
- 塞库金纽马布度>35.43微克/毫升与最佳反应相关 (AUC=0.70,P<0.05).
- 较高的体重和较低的白蛋白水平与降低的secukinumab度相关.
结论:
- 塞库金纽马布度>35.43微克/毫升与牛皮的最佳反应有关.
- 考虑患者的体重和白蛋白水平,以防止剂量不足.
- IL-17A水平与PASI得分或secukinumab度没有相关性.
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K


